Twelve psoriatics have been observed in a controlled study with indomethacin, a nonsteroidal anti-inflammatory agent, as the test drug. No greater subjective or objective benefit was noted from indomethacin than from the placebo.
KERN AB. Indomethacin for Psoriasis. Arch Dermatol. 1966;93(2):239–240. doi:10.1001/archderm.1966.01600200095020
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.